Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Heme Oxygenase 1 ELISA Kit (AC3914)
Cat.#: ASET-2503
Specifications
Description Rat Heme Oxygenase 1 ELISA Kit allows for the in vitro quantitative determination of rat Heme Oxygenase 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1297 Rat Myelin Basic Protein ELISA Kit (AC2708) Quantitative inquiry ASET-1622 Human ASRGL1 ELISA Kit (AC3033) Quantitative inquiry ASET-2438 Human Netrin 1 ELISA Kit (AC3849) Quantitative inquiry ASET-1609 Rat NRG2 ELISA Kit (AC3020) Quantitative inquiry ASET-2452 Rat Orexin A ELISA Kit (AC3863) Quantitative inquiry ASET-1633 Monkey GAP43 ELISA Kit (AC3044) Quantitative inquiry ASET-1371 Human PNMT ELISA Kit (AC2782) Quantitative inquiry ASET-1130 Mouse Leptin ELISA Kit (AC2541) Quantitative inquiry ASET-2329 Mouse Galectin 3 ELISA Kit (AC3740) Quantitative inquiry ASET-1920 Mouse NMDAR2A ELISA Kit (AC3331) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket